We're doing many of the things together in partnership already. For example, market development work is a critical piece of the equation. Even if you have done the.... By the way, we consider bio-pathways as a bit of a framework for decision-making that helped weed out all of those thousands of things, from snake oil salesmen to real, verifiable projects. We used things such as that, which is a solid analytical base, to let the cream of the crop flow to the top. Then from there we need to look at such questions as, who cares whether you can make biochemical X; is there any market for it?
One thing we have learned is that developing a market pathway takes a lot longer runway than anything we have ever imagined. In fact, especially when trying to do biochemicals within an existing supply chain, you have to meet their economic criteria, obviously. You have to meet their quality criteria, obviously. At the same time, you're trying to do it with a whole new technology that has never before been tested.
You can see how that all comes together to create the hesitancy you referred to earlier about going there. Getting over that hesitation is really what I go back to. I know you don't want to hear me talk about programs, but first-in-kind demonstration breaks the mould, shows that it can be done and will be done, and the rest of the tech transfer takes care of itself, especially with our sector.